IRIS

the findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial

Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies.

RUMI, ELISA;CAZZOLA, MARIO
2010-01-01

Abstract

the findings in the current study suggest that aspirin may be effective during the pregnancy of ET patients, especially when the JAK2 (V617F) mutation is present. However, the use of aspirin in pregnancy deserves further investigation in a prospective trial
2010
The Hematology category covers resources concerned with blood, blood-forming tissues, bone marrow, plasma, and transfusions. Coverage also includes resources on specialties such as hemophilia, leukemia, and lymphoma.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
000273687600027
2-s2.0-74749098378
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
8
2
411
413
3
19912517
RIVISTA EMATOLOGICA INTERNAZIONALE
ASPIRIN; PREGNANCY; ESSENTIAL THROMBOCYTHEMIA
http://www.ncbi.nlm.nih.gov/pubmed/19912517
5
info:eu-repo/semantics/article
262
Passamonti, F; Rumi, Elisa; Randi, Ml; Morra, E; Cazzola, Mario
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/225171
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 25
social impact